Dai Longhai, Qin Lujiao, Hu Yumei, Huang Jian-Wen, Hu Zheyang, Min Jian, Sun Yuanxia, Guo Rey-Ting
State Key Laboratory of Biocatalysis and Enzyme Engineering, Hubei Collaborative Innovation Center for Green Transformation of Bio-Resources, Hubei Key Laboratory of Industrial Biotechnology, School of Life Sciences, Hubei University, Wuhan, 430062, PR China.
National Engineering Laboratory for Industrial Enzymes, Tianjin Institute of Industrial Biotechnology, Chinese Academy of Sciences, Tianjin 300308, PR China.
Biochem Biophys Res Commun. 2021 Jan 1;534:73-78. doi: 10.1016/j.bbrc.2020.11.104. Epub 2020 Dec 10.
Glycosylation catalyzed by uridine diphosphate-dependent glycosyltransferases (UGT) contributes to the chemical and functional diversity of a number of natural products. Bacillus subtilis Bs-YjiC is a robust and versatile UGT that holds potentials in the biosynthesis of unnatural bioactive ginsenosides. To understand the molecular mechanism underlying the substrate promiscuity of Bs-YjiC, we solved crystal structures of Bs-YjiC and its binary complex with uridine diphosphate (UDP) at resolution of 2.18 Å and 2.44 Å, respectively. Bs-YjiC adopts the classical GT-B fold containing the N-terminal and C-terminal domains that accommodate the sugar acceptor and UDP-glucose, respectively. Molecular docking indicates that the spacious sugar-acceptor binding pocket of Bs-YjiC might be responsible for its broad substrate spectrum and unique glycosylation patterns toward protopanaxadiol-(PPD) and PPD-type ginsenosides. Our study reveals the structural basis for the aglycone promiscuity of Bs-YjiC and will facilitate the protein engineering of Bs-YjiC to synthesize novel bioactive glycosylated compounds.
由尿苷二磷酸依赖性糖基转移酶(UGT)催化的糖基化作用有助于多种天然产物的化学和功能多样性。枯草芽孢杆菌Bs-YjiC是一种强大且通用的UGT,在非天然生物活性人参皂苷的生物合成中具有潜力。为了理解Bs-YjiC底物选择性的分子机制,我们分别以2.18 Å和2.44 Å的分辨率解析了Bs-YjiC及其与尿苷二磷酸(UDP)的二元复合物的晶体结构。Bs-YjiC采用经典的GT-B折叠结构,包含分别容纳糖受体和UDP-葡萄糖的N端和C端结构域。分子对接表明,Bs-YjiC宽敞的糖受体结合口袋可能是其广泛底物谱以及对原人参二醇(PPD)和PPD型人参皂苷独特糖基化模式的原因。我们的研究揭示了Bs-YjiC苷元选择性的结构基础,并将有助于对Bs-YjiC进行蛋白质工程改造以合成新型生物活性糖基化化合物。